Carlsmed, Inc. Cost of Revenue
Carlsmed, Inc. (CARL) reported Cost of Revenue of $4.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-05
- Carlsmed, Inc. cost of revenue for the quarter ending 2026-06-30 was $4.40M, a 36.84% increase year-over-year.
- Carlsmed, Inc. cost of revenue for the quarter ending 2026-03-31 was $3.69M, a 44.58% increase year-over-year.
- Carlsmed, Inc. cost of revenue for the quarter ending 2025-12-31 was $3.56M, a 49.20% increase year-over-year.
- Carlsmed, Inc. cost of revenue for the quarter ending 2025-09-30 was $3.15M, a 75.61% increase year-over-year.
- Carlsmed, Inc. cost of revenue for fiscal 2025 was $12.47M, a 75.23% increase from fiscal 2024.
- Carlsmed, Inc. cost of revenue for fiscal 2024 was $7.12M.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.40M 10-Q · filed 2026-08-05 | $8.09M 10-Q · filed 2026-08-05 | $11.65M derived: sum of 3 quarters · filed 2026-08-05 | $14.79M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $3.69M 10-Q · filed 2026-05-05 | $7.25M derived: sum of 2 quarters · filed 2026-05-05 | $10.39M derived: sum of 3 quarters · filed 2026-05-05 | $13.61M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $6.70M derived: sum of 2 quarters · filed 2026-02-25 | $9.92M derived: sum of 3 quarters · filed 2026-08-05 | $12.47M 10-K · filed 2026-02-25 |
| 2025-09-30 | $3.15M 10-Q · filed 2025-11-06 | $6.36M derived: sum of 2 quarters · filed 2026-08-05 | $8.91M 10-Q · filed 2025-11-06 | $11.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $3.21M 10-Q · filed 2026-08-05 | $5.77M 10-Q · filed 2026-08-05 | $8.15M derived: sum of 3 quarters · filed 2026-08-05 | $9.94M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $2.55M 10-Q · filed 2026-05-05 | $4.94M derived: sum of 2 quarters · filed 2026-05-05 | $6.73M derived: sum of 3 quarters · filed 2026-05-05 | $8.25M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.18M derived: sum of 2 quarters · filed 2026-02-25 | $5.70M derived: sum of 3 quarters · filed 2026-02-25 | $7.12M 10-K · filed 2026-02-25 |
| 2024-09-30 | $1.79M 10-Q · filed 2025-11-06 | $3.31M derived: sum of 2 quarters · filed 2025-11-06 | $4.73M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $1.52M 10-Q · filed 2025-08-28 | $2.94M 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |